Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-17

Clinical Trial Update: VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria [Phase 3]

View source ↗

Summary

This update reports the completion of VALERIA, a Phase 3 trial evaluating valsartan in combination with lisinopril for hypertensive patients with microalbuminur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED